SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bernard Barlaam, Sabina Cosulich, Sébastien Degorce, Martina Fitzek, Fabrizio Giordanetto, Stephen Green, Tord Inghardt, Laurent Hennequin, Urs Hancox, Christine Lambert-van der Brempt, Rémy Morgentin, Sarah Pass, Patrick Plé, Twana Saleh, Lara Ward, Discovery of 9-(1-anilinoethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as PI3Kβ/δ inhibitors for the treatment of PTEN-deficient tumours, Bioorganic & Medicinal Chemistry Letters, 2014,

    CrossRef

  2. 2
    Fabrizio Giordanetto, Bernard Barlaam, Susanne Berglund, Karl Edman, Olle Karlsson, Jan Lindberg, Sven Nylander, Tord Inghardt, Discovery of 9-(1-phenoxyethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as oral PI3Kβ inhibitors, useful as antiplatelet agents, Bioorganic & Medicinal Chemistry Letters, 2014,

    CrossRef

  3. 3
    Frauke Swieringa, Marijke J.E. Kuijpers, Johan W.M. Heemskerk, Paola E.J. van der Meijden, Targeting platelet receptor function in thrombus formation: The risk of bleeding, Blood Reviews, 2014, 28, 1, 9

    CrossRef

  4. 4
    William A. Denny, Gordon W. Rewcastle, Cancer Drug Design and Discovery, 2014,

    CrossRef

  5. 5
    J. D. McFadyen, S. P. Jackson, Differentiating haemostasis from thrombosis for therapeutic benefit, Thrombosis and Haemostasis, 2013, 110, 5, 859

    CrossRef

  6. 6
    J. Kolic, A. F. Spigelman, G. Plummer, E. Leung, C. Hajmrle, T. Kin, A. M. J. Shapiro, J. E. Manning Fox, P. E. MacDonald, Distinct and opposing roles for the phosphatidylinositol 3-OH kinase catalytic subunits p110α and p110β in the regulation of insulin secretion from rodent and human beta cells, Diabetologia, 2013, 56, 6, 1339

    CrossRef

  7. 7
    J. H. Foley, E. M. Conway, Gas6 gains entry into the coagulation cascade, Blood, 2013, 121, 4, 570

    CrossRef

  8. 8
    Hong Lin, Isoform Selective PI3K-beta Inhibitors, Chinese Journal of Chemistry, 2013, 31, 3
  9. 9
    Jo-Anne Pinson, Zhaohua Zheng, Michelle S. Miller, David K. Chalmers, Ian G. Jennings, Philip E. Thompson, l-Aminoacyl-triazine Derivatives Are Isoform-Selective PI3Kβ Inhibitors That Target Nonconserved Asp862 of PI3Kβ, ACS Medicinal Chemistry Letters, 2013, 4, 2, 206

    CrossRef

  10. 10
    Zhaohua Zheng, Michelle S. Miller, Ian G. Jennings, Philip E. Thompson, Mechanisms of PI3Kβ-Selective Inhibition Revealed by Reciprocal Mutagenesis, ACS Chemical Biology, 2013, 8, 4, 679

    CrossRef

  11. 11
    Hashem A. Dbouk, Jonathan M. Backer, Novel approaches to inhibitor design for the p110β phosphoinositide 3-kinase, Trends in Pharmacological Sciences, 2013, 34, 3, 149

    CrossRef

  12. 12
    Alessandra Ghigo, Fulvio Morello, Alessia Perino, Emilio Hirsch, Therapeutic applications of PI3K inhibitors in cardiovascular diseases, Future Medicinal Chemistry, 2013, 5, 4, 479

    CrossRef

  13. 13
    S. P. JACKSON, S. M. SCHOENWAELDER, Antithrombotic phosphoinositide 3-kinase β inhibitors in humans: a ‘shear’ delight!, Journal of Thrombosis and Haemostasis, 2012, 10, 10
  14. 14
    Fabrizio Giordanetto, Andreas Wållberg, Saswati Ghosal, Tommy Iliefski, Johan Cassel, Zhong-Qing Yuan, Henrik von Wachenfeldt, Søren M. Andersen, Tord Inghardt, Anders Tunek, Sven Nylander, Discovery of phosphoinositide 3-kinases (PI3K) p110β isoform inhibitor 4-[2-hydroxyethyl(1-naphthylmethyl)amino]-6-[(2S)-2-methylmorpholin-4-yl]-1H-pyrimidin-2-one, an effective antithrombotic agent without associated bleeding and insulin resistance, Bioorganic & Medicinal Chemistry Letters, 2012, 22, 21, 6671

    CrossRef